Impact of KRAS mutations and co-mutations on clinical outcomes in pancreatic ductal adenocarcinoma.

Impact of KRAS mutations and co-mutations on clinical outcomes in pancreatic ductal adenocarcinoma. NPJ Precis Oncol. 2024 Feb 03; 8(1):27.

View in: PubMed